Evidence map›Paper›PMID 41917462›Full record

ArticleNature biotechnology2026

Scalable single-cell total RNA sequencing unifies coding and noncoding transcriptomics.

Alina Isakova, Daniel Dan Liu, Ivana Cvijović, Rahul Sinha, Anna E Eastman, Sirle Saul, Angela M Detweiler, Norma Neff, Shirit Einav, Irving L Weissman and 1 more

Abstract read
In one paragraph

Article in Nature biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. The dark genome in cardiovascular medicine.European heart journal · 2026
    Review
  2. Gigabase-scale deletion scanning of the human genome.bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Alina IsakovaDepartment of Bioengineering, Stanford University, Stanford, CA, USA. isakova@stanford.edu.ORCID http://orcid.org/0000-0003-1113-6889
Daniel Dan LiuInstitute for Stem Cell Biology and Regenerative Medicine, Stanford Medicine, Stanford, CA, USA.
Ivana CvijovićDepartment of Applied Physics, Stanford University, Stanford, CA, USA.
Rahul SinhaInstitute for Stem Cell Biology and Regenerative Medicine, Stanford Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0001-7511-0798
Anna E EastmanInstitute for Stem Cell Biology and Regenerative Medicine, Stanford Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-1455-291X
Sirle SaulDepartment of Medicine, Department of Microbiology and Immunology, Stanford University, Stanford, CA, USA.
Angela M DetweilerChan Zuckerberg Biohub, San Francisco, CA, USA.
Norma NeffChan Zuckerberg Biohub, San Francisco, CA, USA.
Shirit EinavDepartment of Medicine, Department of Microbiology and Immunology, Stanford University, Stanford, CA, USA.ORCID http://orcid.org/0000-0001-6441-4171
Irving L WeissmanInstitute for Stem Cell Biology and Regenerative Medicine, Stanford Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0002-9077-7467
Stephen R QuakeDepartment of Bioengineering, Stanford University, Stanford, CA, USA. steve@quake-lab.org.ORCID http://orcid.org/0000-0002-1613-0809

Funding

Advancing the development of a novel class of small molecules for treating pan-coronavirus infectionsR01AI158569 · NIAID · STANFORD UNIVERSITY · PI EINAV, SHIRIT · 2021 to 2025
$3.7M
NIAID NIH HHS R01 AI158569United States Department of Defense | Defense Threat Reduction Agency (DTRA) HDTRA11810039U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) RO1AI158569
6 · The paper itself

Abstract

Current single-cell RNA atlases largely capture polyadenylated transcripts while missing critical regulatory layers from noncoding RNA. To address this, we develop a generalizable framework that adapts total RNA profiling for use in standard droplet-based platforms and captures a broad complement of coding and noncoding RNAs using a unified pipeline. Applying this approach to the developing human brain, we generate a dataset mapping diverse RNA biotypes across all neuronal and non-neuronal lineages, revealing biotype-specific expression programs with cell-type and temporal specificity. Tracking microRNA dynamics in Cajal-Retzius neurons, transient and early-born neurons in the cortex, we show the enrichment and target anticorrelation of MIR137, associated with schizophrenia and intellectual disability, suggesting tight regulatory control. We apply TotalX to human peripheral blood mononuclear cells and identify transcriptional modules combining coding and noncoding RNAs and tRNA dynamics. In addition, we analyze dengue-infected hepatocytes and capture non-adenylated viral transcripts that distinguish infection states. This expanded coverage helps with understanding cellular identity and gene regulation at the atlas scale.

Identifiers

PMID41917462
PMCPMC13268204

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.